Video

Manage Your Dermatology Practice: Mastering Communication With Patients About Their Expectations
- Author:
- Gary Goldenberg, MD
Communicating expectations to patients at their first visit and at follow-up is an important aspect of managing your dermatology practice. Dr....
Video

Manage Your Dermatology Practice: Creating a Strong Online Presence
- Author:
- Gary Goldenberg, MD
Managing a dermatology practice involves having a strong online presence that utilizes your practice's Web site and social media. Dr. Gary...
Article

Filler Placement
- Author:
- Gary Goldenberg, MD
In a recently published article in the Journal of Cosmetic Dermatology (2014;13:91-98), Goodier et al compared low volume deep placement...
Audio

Pros and Cons of Devices for Rosacea
- Author:
- Gary Goldenberg, MD
Dr. Gary Goldenberg discusses lasers and light sources that are ideal for treating rosacea patients.
Article

Devices and Topical Agents for Rosacea Management
- Author:
- Yasaman Mansouri, MD
- Gary Goldenberg, MD
Rosacea is a chronic inflammatory disease that predominantly affects facial skin in light-skinned individuals and can be divided into 4 subtypes....
Article

Hyaluronic Acid Filler for Tear Trough Deformity
- Author:
- Gary Goldenberg, MD
De Pasquale and colleagues (Aesthetic Plast Surg. 2013;37:587-591) published a review of the use of hyaluronic acid (HA) fillers for tear...
Article
Field Therapy in the Treatment of Actinic Keratosis
- Author:
- Marcel Perl, MD
- Gary Goldenberg, MD
Actinic keratosis (AK) treatment represents a large and ever-increasing burden to our health care system, with the direct cost of therapy...
Article

OnabotulinumtoxinA Approved for Treatment of Crow’s-feet
- Author:
- Gary Goldenberg, MD
The US Food and Drug Administration recently approved a new use for Botox Cosmetic (onabotulinumtoxinA)(Allergan, Inc): temporary improvement in...
Article

Fraxel for Actinic Keratosis: A New Therapeutic Option
- Author:
- Gary Goldenberg, MD
Weiss and colleagues (J Am Acad Dermatol. 2013;68:98-102) conducted a 6-month safety, tolerance, and efficacy trial of nonablative 1927-nm...